“Phase I study of single-agent and combined checkpoint inhibition after allogeneic hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence

Type of Cancer
Hematological Malignancies

Phase

Division (Location)

Study ID

NCT#

Brief Description
“Phase I study of single-agent and combined checkpoint inhibition after allogeneic hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.